Japan Suspends Operations At Mitsubishi Tanabe Pharma, Bipha Unit
This article was originally published in PharmAsia News
Executive Summary
Japanese authorities ordered a temporary halt to Mitsubishi Tanabe Pharma's business and that of its subsidiary, Bipha